# CONMED CORPORATION (CNMD) FY2026 Q2 P&L / Income Statement

- Company: CONMED CORPORATION (CNMD)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-29, accession number 0000816956-26-000102
- Page: https://plicit.ai/financials/cnmd/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/cnmd-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 343,488,000 US dollars
- **Cost of sales**: 146,030,000 US dollars
- **Gross profit**: 197,458,000 US dollars
- **Operating expenses**: 161,053,000 US dollars
- **Income from operations**: 36,405,000 US dollars
- **Other income (expense), net (calculated)**: negative 5,058,000 US dollars
- **Income before income taxes**: 31,347,000 US dollars
- **Provision for income taxes**: 8,276,000 US dollars
- **Net income**: 23,071,000 US dollars
- **Orthopedic Surgery**: 152,315,000 US dollars
- **General Surgery**: 191,173,000 US dollars
- **Selling and administrative expense**: 145,553,000 US dollars
- **Research and development expense**: 15,500,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.